We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ADYEN:EURONEXT AMSTERDAMAdyen NV analysis

Data as of Oct 16, 2026 - not real-time

Latest price
€956.30
Risk: medium
5/10Medium risk

Summary

Adyen N.V. is priced at €956.30 and its moving averages line up in bearish order, the shorter trailing the longer. Across the trailing 30 sessions it lost 6.8%. RSI sits at 61.1, which reads as approaching overbought, and MACD momentum is bullish. The recent range runs from support at €843.50 up to resistance at €966.80.
On valuation the read is undervalued — earnings multiple of 26.9 versus a 31.0 sector average, below the peer group. Analyst price targets sit 43.9% above the current price. Revenue is growing at 18.9% on a 43.6% profit margin.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 35.8%, a beta of 0.39 and a maximum drawdown of 48.4%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
Near-term and long-term part ways here — hold short-term against buy longer out, with 5/10 conviction on the long call.

Top market events

  • H1 net revenue rose 19.00 percent to EUR 1,302.90 million. Adyen stock costs EUR 876.00 on October 9
  • Adyen booked EUR 1.30 billion net revenue in the first half of 2026, up 19 percent. Adyen stock cost
  • First half of 2026: volume rose 24.00 percent, revenue 19.00 percent. Adyen stock is EUR 907.40 on O

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 968.81
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 26.9 versus sector average of 31.0
  • Trading below the 200-day average of 968.81

Long term

> 3 years

Positive

Model confidence5/105 out of 10

Key factors

  • P/E of 26.9 versus sector average of 31.0
  • Analyst targets imply +43.9% versus the current price
  • Profit margin of 43.6% is healthy

Key metrics

Financial health

Revenue Growth18.90%
Profit Margin43.55%
P/E Ratio26.9
ROE21.27%
ROA5.24%
Debt/Equity6.93
P/B Ratio5.1
Op. Cash Flow€649.5M
Free Cash Flow€-1190886784
Industry P/E31.0

Technical analysis

TrendBearish
RSI61.1
Support€843.50
Resistance€966.80
MA 20€886.08
MA 50€956.70
MA 200€968.81
MACDBullish
VolumeDecreasing
Fear & Greed Index92.63

Valuation

Fair Value€751.81
Target Price€1,375.94
Upside/Downside43.88%
GradeUndervalued
TypeGrowth

Risk assessment

Beta0.39
Volatility35.84%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.